Predicted to enable integrin binding activity. Involved in negative regulation of epidermal growth factor receptor signaling pathway; regulation of vulval development; and vulval cell fate specification. Located in basement membrane; contractile muscle fiber; and lateral plasma membrane. Expressed in several structures, including Psub4; Z2; Z3; distal tip cell; and vulval cell. Is an ortholog of human TLN2 (talin 2).
Is affected by several genes including unc-25; alg-1; and lin-35 based on RNA-seq and microarray studies. Is affected by bortezomib; Sirolimus; and allantoin based on RNA-seq and microarray studies.
Predicted to be located in membrane. Is an ortholog of human SLC35F3 (solute carrier family 35 member F3) and SLC35F4 (solute carrier family 35 member F4).
Enables sequence-specific DNA binding activity. Involved in cell fate specification; chordate pharyngeal muscle development; and positive regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. Predicted to be part of chromatin. Expressed in several structures, including MSaa; MSpa; MSpp; head neurons; and intestine.